Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE4
60 participants
INTERVENTIONAL
2020-11-02
2027-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cluster Headache Cortivazol Injection (CHCI)
NCT00804895
Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache
NCT01151631
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
NCT04814381
French Database of Occipital Nerves Stimulation in the Treatment of Refractory Chronic Headache Disorders
NCT01842763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Verapamil
administration of verapamil to treat cluster headache
Verapamil
Patients in groupe A require verapamil initiation as a preventive treatment and patients in group B are patients already undergoing a verapamil treatment for their Cluster Headache.
The doses of verapamil are increased for the patients in group A, after a clinical examination an electrocardiogram, and a blood test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verapamil
Patients in groupe A require verapamil initiation as a preventive treatment and patients in group B are patients already undergoing a verapamil treatment for their Cluster Headache.
The doses of verapamil are increased for the patients in group A, after a clinical examination an electrocardiogram, and a blood test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient suffering from Cluster Headache (according to the l'ICHD-3 diagnostic criterias)
* patients affiliated to the social security
* patient that has given his full written consent to participate in the study
* female patients participating in the study must be using an efficient contraception for more than 1 month prior to the beginning of the study
Exclusion Criteria
* patient observing a treatment with ivabradine (Procoralan®), bétablockers, colchicine, l'esmolol, triazolam, quinidine.
* patient under justicial protection
* patient breastfeeding, or pregnant
* patient suffering from a neuromuscular transmisson disease
* patient with a pacemaker
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, CHUN, France
AP-HP Hôpital la Timone
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-API-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.